Cardiac Manifestations of Lyme Disease.
| Autor: | Maliha M; From the Department of Medicine, Jacobi Medical Center and Albert Einstein College of Medicine, Bronx, NY., Abittan N; Departments of Cardiology and Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY., Frishman WH; Department of Medicine, New York Medical College, Valhalla, NY., Aronow WS; Departments of Cardiology and Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY., Harburger J; Departments of Cardiology and Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cardiology in review [Cardiol Rev] 2024 Oct 24. Date of Electronic Publication: 2024 Oct 24. |
| DOI: | 10.1097/CRD.0000000000000807 |
| Abstrakt: | Lyme disease (LD) is an inflammatory disorder caused by an infectious bacterial agent and is the most common tick-borne illness in the United States and Europe. About 1.5-10% of adults infected with LD develop cardiac complications. This review summarizes the current knowledge of the epidemiology, pathophysiology, and diagnosis of Lyme carditis (LC), as well as the different manifestations of LD in the cardiovascular system. This review will primarily highlight the effect of LD on the cardiac conduction system and also discuss its effect on the myocardium, pericardium, valves, and coronary arteries. The management and prognosis of LC will be reviewed here as well. While this is a comprehensive review of the current literature on LC, there remain many questions regarding the complex relationship between LD and the heart. Competing Interests: Disclosure: The authors declare no conflict of interest. (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|